CUL2
Cullin-2
Also known as: CUL2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q13617
- Gene
- CUL2
- Ensembl
- ENSG00000108094
- Chromosome
- 10
- Canonical length
- 745 aa
- Protein class
- Cancer-related genes, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
Enables ubiquitin ligase complex scaffold activity and ubiquitin protein ligase binding activity. Involved in ubiquitin-dependent protein catabolic process via the C-end degron rule pathway. Located in nucleoplasm. Part of Cul2-RING ubiquitin ligase complex. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
745 residues, UniProt reviewed canonical sequence.
>Q13617|CUL2
1 MSLKPRVVDF DETWNKLLTT IKAVVMLEYV ERATWNDRFS DIYALCVAYP EPLGERLYTE
61 TKIFLENHVR HLHKRVLESE EQVLVMYHRY WEEYSKGADY MDCLYRYLNT QFIKKNKLTE
121 ADLQYGYGGV DMNEPLMEIG ELALDMWRKL MVEPLQAILI RMLLREIKND RGGEDPNQKV
181 IHGVINSFVH VEQYKKKFPL KFYQEIFESP FLTETGEYYK QEASNLLQES NCSQYMEKVL
241 GRLKDEEIRC RKYLHPSSYT KVIHECQQRM VADHLQFLHA ECHNIIRQEK KNDMANMYVL
301 LRAVSTGLPH MIQELQNHIH DEGLRATSNL TQENMPTLFV ESVLEVHGKF VQLINTVLNG
361 DQHFMSALDK ALTSVVNYRE PKSVCKAPEL LAKYCDNLLK KSAKGMTENE VEDRLTSFIT
421 VFKYIDDKDV FQKFYARMLA KRLIHGLSMS MDSEEAMINK LKQACGYEFT SKLHRMYTDM
481 SVSADLNNKF NNFIKNQDTV IDLGISFQIY VLQAGAWPLT QAPSSTFAIP QELEKSVQMF
541 ELFYSQHFSG RKLTWLHYLC TGEVKMNYLG KPYVAMVTTY QMAVLLAFNN SETVSYKELQ
601 DSTQMNEKEL TKTIKSLLDV KMINHDSEKE DIDAESSFSL NMNFSSKRTK FKITTSMQKD
661 TPQEMEQTRS AVDEDRKMYL QAAIVRIMKA RKVLRHNALI QEVISQSRAR FNPSISMIKK
721 CIEVLIDKQY IERSQASADE YSYVALocalizationUniProt · AlphaFold · HPA
Whether an antibody against CUL2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.28
- Highest tissue expression
- 30 nTPM
Expression across tissuesHPA
Tissue
- testis: 30 nTPM
- skeletal muscle: 27 nTPM
- tongue: 25 nTPM
- parathyroid gland: 15 nTPM
- liver: 14 nTPM
- tonsil: 14 nTPM
Single-cell type
- early spermatids: 418 nCPM
- late spermatids: 291 nCPM
- late primary spermatocytes: 182 nCPM
- syncytiotrophoblasts: 78 nCPM
- erythrocyte progenitors: 78 nCPM
- neutrophil progenitors: 74 nCPM
Immune cell
- T-reg: 15 nTPM
- MAIT T-cell: 14 nTPM
- memory CD8 T-cell: 13 nTPM
- non-classical monocyte: 13 nTPM
- intermediate monocyte: 12 nTPM
- naive CD8 T-cell: 12 nTPM
Brain region
- hypothalamus: 20 nTPM
- cerebellum: 19 nTPM
- hippocampal formation: 19 nTPM
- basal ganglia: 19 nTPM
- pons: 18 nTPM
- cerebral cortex: 18 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about CUL2.
Disease | GeneticClinVar
1 pathogenic / likely-pathogenic of 108 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.09
- gnomAD pLI
- 1
- gnomAD missense Z
- 3.25
- DepMap mean gene effect
- -0.53
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 7% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- G1/S transition of mitotic cell cycle
- intrinsic apoptotic signaling pathway
- negative regulation of beige fat cell differentiation
- proteasome-mediated ubiquitin-dependent protein catabolic process
- protein ubiquitination
- SCF-dependent proteasomal ubiquitin-dependent protein catabolic process
- ubiquitin-dependent protein catabolic process via the C-end degron rule pathway
Molecular functions
- protein-macromolecule adaptor activity
- ubiquitin ligase complex scaffold activity
- ubiquitin protein ligase binding
- ubiquitin-protein transferase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Cullin, N-terminal
- Cullin, conserved site
- Cullin homology domain
- Cullin repeat-like-containing domain superfamily
- Cullin, neddylation domain
- Cullin homology domain superfamily
- Winged helix-like DNA-binding domain superfamily
- Winged helix DNA-binding domain superfamily
- Cullin
- Cullin-like, alpha+beta domain
- Cullin alpha solenoid domain
- Cullin protein neddylation domain
- Cullin alpha+beta domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CUL2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CUL2 as an antibody target. Whether an autoantibody or antibody against CUL2 could matter depends on whether native CUL2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CUL2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CUL2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...